Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary P Wormser

Showing results (81-90 of 312) with videos related to

Pageof 32
Sort By:
The Pediatric Infectious Disease Journal|October 19, 2019
Is Doxycycline Appropriate for Routine Treatment of Young Children With Erythema Migrans?Gary P Wormser, Franc Strle, Eugene D Shapiro
The American Journal of Medicine|March 7, 2022
The ReplyPaul G Auwaerter, Takaaki Kobayashi, Gary P Wormser
The American Journal of Medicine|August 5, 2021
Guidelines for Lyme Disease Are UpdatedPaul G Auwaerter, Takaaki Kobayashi, Gary P Wormser
Arthritis and Rheumatism|January 17, 2012
The Toll of a TLR1 polymorphism in lyme disease: a tale of mice and menTimothy J Sellati, Bikash Sahay, Gary P Wormser
Emerging Infectious Diseases|July 21, 2021
Comparison of Lyme Disease in the United States and EuropeAdriana R Marques, Franc Strle, Gary P Wormser
The American Journal of Medicine|February 12, 2022
The ReplyPaul G Auwaerter, Takaaki Kobayashi, Gary P Wormser
Antimicrobial Agents and Chemotherapy|December 26, 2001
Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H miceCharles Pavia, Mario A Inchiosa, Gary P Wormser
Journal of the American Academy of Nurse Practitioners|March 11, 2004
Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk populationDonna McKenna, Yolanda Faustini, John Nowakowski, et al.
Ticks and Tick-Borne Diseases|August 30, 2018
Public health and patient safety concerns merit retention of Lyme borreliosis-associated spirochetes within the genus Borrelia, and rejection of the genus novum BorreliellaBrian Stevenson, Volker Fingerle, Gary P Wormser, et al.
Lancet (London, England)|September 10, 2011
Lyme borreliosisGerold Stanek, Gary P Wormser, Jeremy Gray, et al.
Pageof 32

Showing results (81-90 of 312) with videos related to

Sort By:
Pageof 32
The Pediatric Infectious Disease Journal|October 19, 2019
Is Doxycycline Appropriate for Routine Treatment of Young Children With Erythema Migrans?Gary P Wormser, Franc Strle, Eugene D Shapiro
The American Journal of Medicine|March 7, 2022
The ReplyPaul G Auwaerter, Takaaki Kobayashi, Gary P Wormser
The American Journal of Medicine|August 5, 2021
Guidelines for Lyme Disease Are UpdatedPaul G Auwaerter, Takaaki Kobayashi, Gary P Wormser
Arthritis and Rheumatism|January 17, 2012
The Toll of a TLR1 polymorphism in lyme disease: a tale of mice and menTimothy J Sellati, Bikash Sahay, Gary P Wormser
Emerging Infectious Diseases|July 21, 2021
Comparison of Lyme Disease in the United States and EuropeAdriana R Marques, Franc Strle, Gary P Wormser
The American Journal of Medicine|February 12, 2022
The ReplyPaul G Auwaerter, Takaaki Kobayashi, Gary P Wormser
Antimicrobial Agents and Chemotherapy|December 26, 2001
Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H miceCharles Pavia, Mario A Inchiosa, Gary P Wormser
Journal of the American Academy of Nurse Practitioners|March 11, 2004
Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk populationDonna McKenna, Yolanda Faustini, John Nowakowski, et al.
Ticks and Tick-Borne Diseases|August 30, 2018
Public health and patient safety concerns merit retention of Lyme borreliosis-associated spirochetes within the genus Borrelia, and rejection of the genus novum BorreliellaBrian Stevenson, Volker Fingerle, Gary P Wormser, et al.
Lancet (London, England)|September 10, 2011
Lyme borreliosisGerold Stanek, Gary P Wormser, Jeremy Gray, et al.
Pageof 32